Effects of nitric oxide synthase inhibitor on hemodynamic change and O2 delivery in septic dogs.
To elucidate the role of nitric oxide (NO) in septic shock, we measured hemodynamic and pulmonary gas changes in anesthetized dogs after intravenous administration of bacterial lipopolysaccharide (LPS) with or without NO synthase inhibitor, NG-nitro-L-arginine (L-NNA). Infusion of LPS (250 ng.kg-1.min-1) for 2 h decreased mean arterial pressure over 1-4 h. Although L-NNA (10 mg/kg) blocked LPS-induced hypotension, it decreased cardiac index, oxygen delivery index, arterial pH, and arterial PO2 and increased systemic vascular resistance index in the presence or absence of LPS. Administration of NG-nitro-D-arginine (D-NNA, 10 mg/kg) alone caused fewer hemodynamic effects (increased systemic vascular resistance index and decreased cardiac index) than L-NNA alone. Our study provides evidence that L-NNA prevents endotoxin-induced hypotension but decreases cardiac output and oxygen delivery, effects that may, in part, be due to a nonspecific NO synthase-independent event. Thus clinical use of NO synthase inhibitors for the treatment of septic shock should be cautiously considered.
Mitaka
C
C
Department of Intensive Care, Tokyo Medical and Dental University, Japan.
Hirata
Y
Y
Ichikawa
K
K
Uchida
T
T
Yokoyama
K
K
Nagura
T
T
Tsunoda
Y
Y
Amaha
K
K
D000594:Amino Acid Oxidoreductases / Q000037:antagonists & inhibitors*; D000818:Animals; D001120:Arginine / Q000031:analogs & derivatives / Q000494:pharmacology; D001682:Biological Availability; D004285:Dogs; D006439:Hemodynamics / Q000187:drug effects; D008070:Lipopolysaccharides / Q000494:pharmacology; D019001:Nitric Oxide Synthase; D019335:Nitroarginine; D010100:Oxygen / Q000097:blood*; D011659:Pulmonary Gas Exchange / Q000187:drug effects; D012772:Shock, Septic / Q000503:physiopathology
D008070:Lipopolysaccharides; D019335:Nitroarginine; D001120:Arginine; D019001:Nitric Oxide Synthase; D000594:Amino Acid Oxidoreductases; D010100:Oxygen